This site is intended for healthcare professionals
The Home Office has updated the legal classification...
Positive opinions on Lyxumia (lixisenatide), Sayana...
Other new launches, licence changes and updates relevant...
Product overviews prepared by the MIMS team, in a handy slide format.
Slides are initiated, funded & reviewed by the companies specified.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Access the full drug database and quick-reference tables on the go
Find out more